Translation of AI into oncology clinical practice
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Artificial intelligence (AI) is a transformative technology that is capturing popular imagination and can revolutionize biomedicine. AI and machine learning (ML) algorithms have the potential to break through existing barriers in oncology research and practice such as automating workflow processes, personalizing care, and reducing healthcare disparities. Emerging applications of AI/ML in the literature include screening and early detection of cancer, disease diagnosis, response prediction, prognosis, and accelerated drug discovery. Despite this excitement, only few AI/ML models have been properly validated and fewer have become regulated products for routine clinical use. In this review, we highlight the main challenges impeding AI/ML clinical translation. We present different clinical use cases from the domains of radiology, radiation oncology, immunotherapy, and drug discovery in oncology. We dissect the unique challenges and opportunities associated with each of these cases. Finally, we summarize the general requirements for successful AI/ML implementation in the clinic, highlighting specific examples and points of emphasis including the importance of multidisciplinary collaboration of stakeholders, role of domain experts in AI augmentation, transparency of AI/ML models, and the establishment of a comprehensive quality assurance program to mitigate risks of training bias and data drifts, all culminating toward safer and more beneficial AI/ML applications in oncology labs and clinics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High-performance medicine: the convergence of human and artificial intelligence
Topol, E. J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0300-7 · Cited by 10,450 · cited 1×
“Arti fi cial intelligence (AI) systems and machine learning (ML) algorithms are currently transforming biomedicine [1, 2] including the cancer research fi eld and the oncology practice [3 – 6].”
BackgroundAn Experimental Application of the DELPHI Method to the Use of Experts
Dalkey, N., & Helmer, O. (1963) · Management Science · doi:10.1287/mnsc.9.3.458 · Cited by 6,061
Rajkomar, A., Dean, J., & Kohane, I. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1814259 · Cited by 4,579
The future of digital health with federated learning
Rieke, N., Hancox, J., Li, W., Milletarì, F., Roth, H. R., Albarqouni, S., Bakas, S., Galtier, M. N., Landman, B. A., Maier-Hein, K., et al. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-00323-1 · Cited by 4,015
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
Ayers, M., Lunceford, J., Nebozhyn, M., Murphy, E., Loboda, A., Kaufman, D. R., Albright, A., Cheng, J. D., Kang, S. P., Shankaran, V., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91190 · Cited by 3,788
The Future of Digital Health with Federated Learning
Rieke, N., Hancox, J., Li, W., Milletari, F., Roth, H., Albarqouni, S., Bakas, S., Galtier, M. N., Landman, B., Maier-Hein, K., et al. (2020) · arXiv · doi:10.48550/arxiv.2003.08119 · Cited by 3,495
Machine Learning Applications in Cancer Prognosis and Prediction
Kourou, K., Exarchos, T. P., Exarchos, K. P., Karamouzis, M. V., & Fotiadis, D. I. (2015) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2014.11.005 · Cited by 3,338 · cited 1×
“These applications span the spectrum of oncology from screening and early detection [7 – 9], cancer diagnosis [10 – 12], cancer prognosis and prediction [13, 14], radiological imaging and therapeutics [5], to disruptive applications in hematology [15] and radiation oncology [16 – 18].”
BackgroundTumor mutational burden and response rate to PD-1 inhibition
Yarchoan, M., Hopkins, A., & Jaffee, E. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1713444 · Cited by 3,230 · cited 1×
“In terms of genomic sequencing, promising immunotherapeutic biomarkers included the tumor mutational burden (TMB) [70], aneuploidy (also known as somatic copy number alterations, SCNAs) [71], neoantigen prediction [72], HLA-I [72, 73] genotypes, T-cell repertoire [74], and germline genetic variations [75].”
BackgroundApplications of machine learning in drug discovery and development
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0024-5 · Cited by 3,228
Key challenges for delivering clinical impact with artificial intelligence
Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G., & King, D. (2019) · BMC Medicine · doi:10.1186/s12916-019-1426-2 · Cited by 3,136
Cited by
Large Language Model‐Based Chatbots in Higher Education
Yigci, D., Eryilmaz, M., Yetisen, A. K., Tasoglu, S., & Ozcan, A. (2025) · Advanced Intelligent Systems · doi:10.1002/aisy.202400429 · Cited by 113
Duan, S., Liu, C., Rong, T., Zhao, Y., & Liu, B. (2025) · BMC Medical Education · doi:10.1186/s12909-025-07177-9 · Cited by 85
“Moreover, AI tools assist instructors in optimizing the teaching process and provide personalized learning support and clinical practice functionality for students [14, 15].”
Artificial Intelligence in Clinical Oncology: From Productivity Enhancement to Creative Discovery
Kuno, M., Osumi, H., Udagawa, S., Yoshikawa, K., Ooki, A., Shinozaki, E., Ishikawa, T., Oba, J., Yamaguchi, K., & Sakurada, K. (2025) · Current Oncology · doi:10.3390/curroncol32110588 · Cited by 7
Explainable artificial intelligence for multi-modal cancer analysis: from genomics to immunology
Zhang, M., & Yin, L. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105040 · Cited by 5
Human-machine interaction in the age of generative AI
Niraula, D., Shotande, M. O., & El Naqa, I. (2025) · The Cancer Journal · doi:10.1097/ppo.0000000000000797 · Cited by 1
Metadata
- Authors
- El Naqa, I., Karolak, A., Luo, Y., Folio, L., Tarhini, A. A., Rollison, D., & Parodi, K.
- Venue
- Oncogene
- Published
- 2023-09-08
- Volume
- 42
- Issue
- 42
- Pages
- 3089-3097
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W4386545809
- Cited by
- 81
- References
- 50
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Translation of AI into oncology clinical practice. https://app.cochat.ai/papers/10.1038/s41388-023-02826-z
- The paper
- El Naqa, I., Karolak, A., Luo, Y., Folio, L., Tarhini, A. A., Rollison, D., & Parodi, K. (2023). Translation of AI into oncology clinical practice. Oncogene. https://doi.org/10.1038/s41388-023-02826-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.